Herpes simplex virus (HSV)-specific T cells are essential to control and resolve genital herpes (GH
In humans, gd T cells account for ∼0.5%-6% of peripheral blood (PB) T cells, mainly expressing the Vg9Vd2 T cell receptor (TCR) variable gene segments [3] . Antigenic targets of Vg9Vd2 T cells include heat shock proteins, bacterial superantigens, and, especially, the nonpeptide prenyl pyrophosphates (PPPs). The PPPs, including isopentenyl pyrophosphate (IPP), are essential metabolites of both prokaryotic and eukaryotic cells [4] . Increases in the number of Vg9Vd2 T cells and/or localization of Vg9Vd2 T cells to sites of infection have been documented in bacterial, parasitic, and viral diseases, including human Epstein-Barr virus (EBV) and HSV infections [5] . Human PB-derived Vg9Vd2 T cells have been demonstrated to lyse Daudi Burkitt lymphoma cells and HSV-infected, but not mock-infected, target cells [6, 7] . Moreover, a direct role of HSV-specific gd T cells in providing protective immunity has been demonstrated in an experimental mouse model of HSV type 1 (HSV-1) infection [8] .
Detailed studies of gd T cells in humans with GH are lacking [9] . In the present study, we investigated the phenotype and functional characteristics of gd T cells recovered and expanded from lesions of patients with GH.
Materials and methods. The local investigational review board approved the study protocol, and informed consent was obtained from all patients included in the present study. Seventeen healthy HIV-seronegative individuals who either were clinically suspected of having GH or had a history of GH were enrolled in the study. All patients with GH were treated with valacyclovir (500 mg twice daily) for 5 days. Five patients who had either lichen sclerosus, pruritus vulvae, or condylomata acuminata were included as control subjects (table 1) . Swab specimens or punch biopsy specimens (diameter, 4 mm) from the vulva, penis, or perianal area were obtained for diagnostic virus culture and HSV subtype-specific DNA polymerase chain reaction analyses [10] . For swab specimen recovery, vesicle contents and ulcer base cells were obtained using a sterile spatula and were added to 1 mL of RPMI 1640 medium (Biowhittaker) supplemented with 10% heat-inactivated pooled human serum and antibiotics (referred to as "R10H medium"). Punch biopsy specimens were divided into 2 equal parts for virus and T cell culture or immunohistologic analyses. Isolation of PB mononuclear cells and generation of EBV-transformed B lymphoblastoid cell lines (BLCLs) were performed as described elsewhere [10] .
T cell lines (TCLs) were generated from surplus biopsy specimens that were minced and treated with collagenase, as described elsewhere for corneal tissue samples [10] . For swab specimens, cell suspensions were washed twice and were resuspended in R10H medium supplemented with 50 U/mL human recombinant interleukin 2 (rIL-2; Eurocetus) and 50 mmol/L acyclovir (Glaxo Wellcome). The cells were divided over ∼10 wells of a 96-well round-bottom microtiter plate and were nonspecifically stimulated with 1 mg/mL phytohemagglutinin-L (PHA-L; Boehringer Mannheim) in the presence of g-irradiated (3 Gy) allogeneic feeder cell mixture, as described elsewhere [10] . After 1 round of stimulation (or after 2 rounds, when insufficient cell numbers were obtained), the intralesional TCLs were aliquoted and frozen at Ϫ135ЊC. The cloning and maintenance of T cell clones (TCCs) generated from the intralesional TCLs have been described elsewhere [11] . TCLs and TCCs were characterized using 3-color flow cytometric analysis for cell surface expression of CD3, CD4, and CD8 (Dako); TCR ab (Pharmingen), TCR gd (Immunotech), and CD3; or TCR Vd2 (Pharmingen), TCR Vg9 (Immunotech), and CD3. Expression of TCR Vd and Vg family expression were assessed by 2-color flow cytometry that used CD3 in combination with the following monoclonal antibodies: anti-Vd1 (R9.12), anti-Vd3 (P11.5B), anti-Vg2-4 (23D12), Vg3/5 (56.3; monoclonal antibody recognizes Vg3 and some Vg5 gene products), Vg4 (4A11), and Vg8 (R4.5).
BLCLs were infected with HSV-1 (strain McTyre) or HSV-2 (strain MS), at an MOI of ∼5, at 37ЊC for 20 h, or they were left untreated (i.e., they were "mock-infected" BLCLs). T cells ( cells/well), which were removed from culture on day 4 3 ϫ 10 10-12 after restimulation, were cultured, in triplicate, with UVirradiated ( uW/mm 2 ) antigen-presenting cells (2 ϫ 5 ϫ 10 5 ϫ 10 well) in R10H medium with or without IPP [11] . Supernatants were harvested, and the 51 Cr release was measured in a gamma counter. The percentage of specific 51 Cr release was calculated as described elsewhere [10] . The spontaneous release and standard deviations were р25% of the total 51 Cr release and р15% of the mean values, respectively.
To determine the cytokine and chemokine secretion profile of the TCCs, T cells ( cells) were incubated in R10H medium 6 10 with or without plate-coated anti-CD3 (1 mg/mL [UCHT1; Immunotech]) at 37ЊC for 24 h in a CO 2 incubator. Cell-free supernatants were assayed for interleukin (IL)-4, tumor necrosis factor (TNF)-a, interferon (IFN)-g, IL-8 (CXCL8), RANTES (CCL5), and macrophage inflammatory protein-1a (CCL3), by use of compact ELISA kits, according to the manufacturer's instructions (Biosource). The limits of detection of the ELISAs were as follows: for IL-4, 5 pg/mL; for TNF-a and IFN-g, 10 pg/mL; for CXCL8 and CCL3, 20 pg/mL; and for CCL5, 8 pg/mL.
Results. Intralesional TCLs were generated, by mitogenic stimulation of inflammatory cells recovered from scrapings or biopsy specimens, from the genital lesions of 17 patients with GH and 5 patients without GH, to determine the phenotype and functional characteristics of lesion-infiltrating T cells (table  1) . On the basis of clinical and laboratory data, the genital lesions of patients 1-6 and patients 7-17 were defined as HSV-1-induced and HSV-2-induced GH, respectively. All TCLs that were generated predominantly consisted of CD3 + T cells. In contrast to findings for the patients without GH, relatively high numbers of gd T cells, predominantly CD3
were detected in the TCLs of 9 of 17 patients with GH (table  1) . In contrast to the findings of Koelle et al. [9] , NK cells were not recovered from GH lesions. This discrepancy is possibly the result of the different procedures used to generate the TCLs. TCR Vg and Vd subtyping revealed that the majority of the GH-derived gd T cells coexpressed TCR Vg9 and Vd2. Neither the interindividual variation of the ratio of CD4 cells to CD8 cells nor the presence or subtype of gd T cells was significantly correlated with a patient's age, sex, GH specimen source, GH disease entity, HSV type, or the number of days that clinical symptoms were present before sampling (table 1) . T cells of representative TCLs of patients 4 and 7 were cloned by limiting dilution to investigate the functional properties of the intralesional Vg9Vd2 T cells at the clonal level. Resulting Vg9Vd2 TCCs were identified by flow cytometry, and Vg9Vd2-positive TCCs were selected, expanded, and analyzed in proliferative and cytotoxicity assays, for recognition of HSV-infected cells. In both functional assays, none of the Vg9Vd2 TCCs showed reactivity toward HSV-1-or HSV-2-infected autologous BLCLs (table 2 the Vg9Vd2 TCCs studied. Future studies will be conducted to test this hypothesis.
After stimulation with anti-CD3, all Vg9Vd2 TCCs secreted high levels of IFN-g and TNF-a, but they secreted either no or relatively low amounts of IL-4, indicating their Th1-like phenotype. In addition, the activated TCCs produced high levels of the chemokines CXCL8, CCL3, and CCL5 (table 2) . Compared with anti-CD3 stimulation, none of the cytokines but low amounts of the chemokines that were analyzed could be detected in the supernatants of the mock-treated TCC cultures (data not shown).
Discussion. The aim of the present study was to investigate the involvement of gd T cells in the local cellular immune response of patients with GH. Approximately one-half of the intralesional TCLs, which were obtained after nonspecific stimulation of inflammatory cells recovered from affected tissue specimens from patients with GH, had relatively high numbers of gd T cells. The lack of gd T cells in the TCLs of patients without GH suggests that infiltration of gd T cells into affected tissue occurs in patients with GH. This assumption was corroborated by immunohistologic analyses demonstrating intradermal localization of gd T cells, which expressed IFN-g, in the affected skin of patients with GH (data not shown). Accumulation of gd T cells in the affected lesions has also been demonstrated in an experimental mouse model of HSV-2-induced GH [13] . Recently, Sciammas et al. [8] presented conclusive evidence for a direct role of gd T cells in protecting mice from HSV-1-induced abnormalities.
In the present study, none of the GH Vg9Vd2 TCCs proliferated or were cytolytic after stimulation with HSV-infected autologous BLCLs. These results are in contrast to the findings of previous studies. Stimulation of human PB mononuclear cells with autologous HSV-infected phytohemagglutinin blasts led to a vigorous expansion of predominately Vg9Vd2 T cells. These PB-derived Vg9Vd2 T cells lysed Daudi cells and HSV-infected target cells, but not mock-infected target cells, by means of their TCRs, in an HLA-unrestricted manner [6, 7] . Moreover, these T cells displayed a broad reactivity to other antigenic stimuli, such as vaccinia virus-infected target cells, Mycobacterium tuberculosis protein extract, and mycobacterialderived and chemically synthesized PPPs [6, 14] . Of interest, all Vg9Vd2 TCCs that were analyzed in the present study recognized Daudi cells and the PPP isopentenyl pyrophosphate. Human Vg9Vd2 T cells are known to recognize various PPPs with different affinities and to progressively lose their reactivity, during long-term in vitro culture, toward less active compounds and, subsequently, toward more active compounds, such as IPP [15, 16] . This unresponsiveness is, in part, due to a blockade of signaling between the TCR and P21 ras [16] . It has been suggested that HSV-reactive Vg9Vd2 T cells recognize a cellular ligand-most likely, a PPP-that is induced or modified on viral infection of the target cell [5, 6, 12, 14] . As a result, genital HSV infection may induce PPP-specific activation of tissue-infiltrating Vg9Vd2 T cells in 3 ways. First, a PPP with low affinity, compared with that of IPP, is expressed by HSV-infected cells and is recognized by Vg9Vd2 T cells. In contrast to IPP, reactivity toward this ligand may be lost after long-term culture of lesion-derived Vg9Vd2 T cells, as may be the case for the Vg9Vd2 TCCs studied here. Second, PPPs, like IPP, are secreted by prokaryotic cells and are sequestered in eukaryotic cells. Damage of the latter cells (e.g., as a result of HSV infection or inflammation-induced tissue necrosis) may result in the release of these sequestered Vg9Vd2 ligands. Third, PPPs may be deposited locally after microbial superinfection of ulcerated GH lesions. Although none of the patients with GH assessed in the present study showed clinical evidence of microbial superinfection of their herpetic lesions, this option cannot formally be ruled out.
In conclusion, to our knowledge, the present study is the first study to describe the phenotypic and functional characteristics of intralesional gd T cells in patients with GH. Recovery of high numbers of gd T cells-mainly, Vg9Vd2 T cells-was restricted to patients with GH. gd T cells, which are considered to patrol the body for infection and pathologic cell death, are among the first inflammatory cell types found in affected tissues. Early in HSV-induced inflammation, activated Vg9Vd2 T cells secrete antiviral cytokines, such as IFN-g and TNF-a, and chemokines, such as CCL3, CCL5, and CXCL8, that may affect the course of inflammation. CXCL8 is a potent chemoattractant for neutrophils, and expression of CCL3 and CCL5 induces tissue infiltration of monocytes and activated T cells [17] . Recently, it has been shown that both CXCL8 and CCL5 enhanced HSV-specific Th1 CD4 + T cell immune response and protection from virus challenge in mice [18] . The presence of IPP-specific Vg9Vd2 T cells at the site of inflammation, as well as the cytokine and chemokine secretion pattern of such cells, suggests that these cells play a previously unappreciated role in the local inflammatory response of patients with GH. Elaborate immunohistologic studies of GH biopsy specimens are warranted to evaluate the kinetics and effector functions of Vg9Vd2 T cells during the evolution of lesions in patients with GH.
